Tiziana Life Sciences Ltd. Common Shares
TLSA Real Time Price USDRecent trades of TLSA by members of U.S. Congress
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes by institutional investors
Quarterly net insider trading by TLSA's directors and management
Government lobbying spending instances
Estimated quarterly lobbying spending
TLSA Revenue by Segment or Geography
New patents grants
-
Patent Title: Dactinomycin compositions and methods for the treatment of myelodysplastic syndrome and acute myeloid leukemia May. 07, 2024
-
Patent Title: Dactinomycin compositions and methods for the treatment of myelodysplastic syndrome and acute myeloid leukemia Apr. 13, 2021
-
Patent Title: Formulations of milciclib and therapeutic combinations of the same for use in the treatment of cancer Sep. 01, 2020
-
Patent Title: Anti-cd3 antibody formulations Jun. 23, 2020
Federal grants, loans, and purchases
Estimated quarterly amount awarded from public contracts
Recent insights relating to TLSA
Number of mentions of TLSA in WallStreetBets Daily Discussion
Recent picks made for TLSA stock on CNBC
ETFs with the largest estimated holdings in TLSA
- ... Highest Price Target
- ... Median Price Target
- ... Lowest Price Target
|
Analyst
|
Firm
|
Current
|
Previous
|
Date
|
|---|
- Is $TLSA stock a Buy, Sell, or Hold?
- What is the price target for $TLSA stock?
* Analyst consensus is not financial advice. Please see our data disclaimers .
|
Shareholder
|
Shares Held
|
|---|
- Who owns $TLSA stock?
- Who owns the most shares of $TLSA stock?
- What funds own $TLSA stock?
* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view TLSA Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.